Don't be afraid: very old patients treated with Vitamin K antagonists, if...
Results of the EPICA Study (Elderly Patients followed by Italian Centres for Anticoagulation Study), were presented at the ESC Congress 2011 today. This is the largest study on very old patients...
View ArticleMajor risks of dual and triple antithrombotic therapy in patients with newly...
According to Dr. Samy Suissa, Director of Clinical Epidemiology, Jewish General Hospital, and Professor of Epidemiology, McGill University in Montreal, Canada, "treating physicians need to consider the...
View ArticleScientists develop antidote to new anticoagulants
(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic...
View ArticleExcess vitamin E intake not a health concern, study says
Despite concerns that have been expressed about possible health risks from high intake of vitamin E, a new review concludes that biological mechanisms exist to routinely eliminate excess levels of the...
View ArticleESC guide on new oral anticoagulant drugs
A practical guide on the use of the new oral anticoagulants (NOACs) has been produced by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). A guide was needed to...
View ArticleAAP issues guidelines for care of infants born at home
(HealthDay)—Every newborn infant, including those born at home, is entitled to appropriate care, according to a policy statement issued by the American Academy of Pediatrics (AAP) and published online...
View ArticleApixaban in atrial fibrillation: Indications of considerable added benefit
The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation. In an...
View ArticleGPs undertreat women with AF
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than...
View ArticleAnticoagulation in patients with atrial fibrillation undergoing coronary...
A new article in the September 2013 issue of Thrombosis and Haemostasis strives to shed light on the optimal antithrombotic strategy in patients suffering from atrial fibrillation who undergo coronary...
View ArticleBlood thinner dangerous for patients with artificial heart valves, study finds
(HealthDay)—When used by patients with mechanical heart valves, the blood thinner Pradaxa raises the risk of both dangerous clots and bleeding around the heart, a new study says.
View ArticleNeonatal vitamin K refusal tied to nonimmunization
(HealthDay)—While neonatal vitamin K refusal is rare, parents who refuse vitamin K are less likely to immunize their child, according to a study published online Aug. 18 in Pediatrics.
View ArticleRejecting Vitamin K at birth predicts child vaccination refusal
New Zealand parents who turn down vitamin K for their newborns are more than 14 times more likely to not get their children immunised, a new University of Otago study has found.
View ArticleVitamin K deficiency increasingly common as result of vaccine refusal
Vitamin K, which has been administered to newborns as an injection since it was first recommended by the American Academy of Pediatrics in 1961, is vital for blood to clot normally. Despite it being...
View ArticleAnti-vaccine trend has parents shunning newborns' vitamin shot
(HealthDay)—With the recent U.S. measles outbreak, the issue of vaccine refusal has received growing scrutiny. Now doctors are calling attention to a similar problem: Some parents are shunning the...
View ArticleVitamin K shots necessary to prevent internal bleeding in newborns
The growing trend of parents' shunning vaccines has crept into another area that has physicians recommending caution—forgoing vitamin K shots in newborns.
View Article
